Position in BCRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$722,644
+$281,812 QoQ
Shares Held
75,908
+34.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Entropy Technologies, LP holds $8,945,097 across 9 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
23,677 | $3,119,207 | |
| 2 | VTRS |
Viatris Inc
|
211,354 | $2,855,392 | |
| 3 | ALKS |
Alkermes plc.
|
22,885 | $809,213 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
75,908 | $722,644 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
6,307 | $485,008 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
12,649 | $380,987 | |
| 7 | PRGO |
PERRIGO Co plc
|
30,797 | $330,759 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
19,070 | $123,382 |
All Filings in BCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $722,644 | 75,908 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $440,832 | 56,517 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $512,454 | 67,517 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $183,984 | 20,534 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||